64019-93-8,MFCD01697462
Catalog No.:AA00E91G

64019-93-8 | Dipivefrin hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
≥98%
in stock  
$116.00   $81.00
- +
50mg
≥98%
in stock  
$218.00   $152.00
- +
100mg
≥98%
in stock  
$409.00   $286.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00E91G
Chemical Name:
Dipivefrin hydrochloride
CAS Number:
64019-93-8
Molecular Formula:
C19H30ClNO5
Molecular Weight:
387.8982
MDL Number:
MFCD01697462
SMILES:
CNCC(c1ccc(c(c1)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)O.Cl
Properties
Computed Properties
 
Complexity:
463  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
9  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  

Literature

Title: Effects of anti-glaucoma drugs on resistive index of the medial long posterior ciliary artery using color Doppler imaging in Beagle dogs.

Journal: Journal of veterinary science 20110301

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Pupillary supersensitivity and visual disturbance in Parkinson's disease.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20080201

Title: [Cystoid macular edema].

Journal: Bulletin de la Societe belge d'ophtalmologie 20070101

Title: Allergic contact dermatitis from timolol and dorzolamide eye drops.

Journal: Contact dermatitis 20060601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Contact dermatitis by dipivefrine.

Journal: Contact dermatitis 20050301

Title: [Latanoprost topical ophthalmic combinations].

Journal: Oftalmologia (Bucharest, Romania : 1990) 20040101

Title: The effect of topical glaucoma medications evaluated by perimetry.

Journal: The British journal of ophthalmology 20030601

Title: Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601

Title: Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.

Journal: Investigative ophthalmology & visual science 20020401

Title: Contact dermatitis to topical drugs for glaucoma.

Journal: American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 20011201

Title: Cicatricial entropion associated with chronic dipivefrin application.

Journal: Ophthalmic plastic and reconstructive surgery 20010901

Title: [A case of suspected drug-induced ocular pemphigoid].

Journal: Nippon Ganka Gakkai zasshi 20010301

Title: Development of glaucoma after phacoemulsification for removal of cataracts in dogs: 22 cases (1987-1997).

Journal: Journal of the American Veterinary Medical Association 20010101

Title: Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.

Journal: The British journal of ophthalmology 19980401

Title: Corneal vascularization and opacification during long-term use of dipivefrin.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 19950101

Title: Central vein thrombosis and topical dipivalyl epinephrine.

Journal: Acta ophthalmologica 19900801

Title: Systemic hypertension in patients receiving dipivalyl adrenaline for glaucoma.

Journal: BMJ (Clinical research ed.) 19880917

Title: Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.

Journal: Australian journal of ophthalmology 19830801

Title: Edgar DF, et al. Effects of dipivefrin and pilocarpine on pupil diameter, automated perimetry and LogMAR acuity. Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):117-24.

Title: Anderson JA, et al. Effects of echothiophate on enzymatic hydrolysis of dipivefrin. Arch Ophthalmol. 1984 Jun;102(6):913-6.

Title: Introini-Collison I, et al. Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Res. 1992 Feb 14;572(1-2):81-6.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:64019-93-8 Molecular Formula|64019-93-8 MDL|64019-93-8 SMILES|64019-93-8 Dipivefrin hydrochloride
Catalog No.: AA00E91G
64019-93-8,MFCD01697462
64019-93-8 | Dipivefrin hydrochloride
Pack Size: 25mg
Purity: ≥98%
in stock
$116.00 $81.00
Pack Size: 50mg
Purity: ≥98%
in stock
$218.00 $152.00
Pack Size: 100mg
Purity: ≥98%
in stock
$409.00 $286.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00E91G
Chemical Name: Dipivefrin hydrochloride
CAS Number: 64019-93-8
Molecular Formula: C19H30ClNO5
Molecular Weight: 387.8982
MDL Number: MFCD01697462
SMILES: CNCC(c1ccc(c(c1)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)O.Cl
Properties
Complexity: 463  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 26  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 9  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: Effects of anti-glaucoma drugs on resistive index of the medial long posterior ciliary artery using color Doppler imaging in Beagle dogs.

Journal: Journal of veterinary science20110301

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Pupillary supersensitivity and visual disturbance in Parkinson's disease.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society20080201

Title: [Cystoid macular edema].

Journal: Bulletin de la Societe belge d'ophtalmologie20070101

Title: Allergic contact dermatitis from timolol and dorzolamide eye drops.

Journal: Contact dermatitis20060601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Contact dermatitis by dipivefrine.

Journal: Contact dermatitis20050301

Title: [Latanoprost topical ophthalmic combinations].

Journal: Oftalmologia (Bucharest, Romania : 1990)20040101

Title: The effect of topical glaucoma medications evaluated by perimetry.

Journal: The British journal of ophthalmology20030601

Title: Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics20030601

Title: Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.

Journal: Investigative ophthalmology & visual science20020401

Title: Contact dermatitis to topical drugs for glaucoma.

Journal: American journal of contact dermatitis : official journal of the American Contact Dermatitis Society20011201

Title: Cicatricial entropion associated with chronic dipivefrin application.

Journal: Ophthalmic plastic and reconstructive surgery20010901

Title: [A case of suspected drug-induced ocular pemphigoid].

Journal: Nippon Ganka Gakkai zasshi20010301

Title: Development of glaucoma after phacoemulsification for removal of cataracts in dogs: 22 cases (1987-1997).

Journal: Journal of the American Veterinary Medical Association20010101

Title: Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.

Journal: The British journal of ophthalmology19980401

Title: Corneal vascularization and opacification during long-term use of dipivefrin.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics19950101

Title: Central vein thrombosis and topical dipivalyl epinephrine.

Journal: Acta ophthalmologica19900801

Title: Systemic hypertension in patients receiving dipivalyl adrenaline for glaucoma.

Journal: BMJ (Clinical research ed.)19880917

Title: Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.

Journal: Australian journal of ophthalmology19830801

Title: Edgar DF, et al. Effects of dipivefrin and pilocarpine on pupil diameter, automated perimetry and LogMAR acuity. Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):117-24.

Title: Anderson JA, et al. Effects of echothiophate on enzymatic hydrolysis of dipivefrin. Arch Ophthalmol. 1984 Jun;102(6):913-6.

Title: Introini-Collison I, et al. Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Res. 1992 Feb 14;572(1-2):81-6.

Building Blocks More >
61397-58-8
61397-58-8
KETOCONAZOLE INTERMEDIATE
AA00E9AC | MFCD09033165
57382-97-5
57382-97-5
Ethyl 2-thiopheneacetate
AA00E9GD | MFCD00005457
5860-70-8
5860-70-8
2-Carbamoylpyridine-3-carboxylic acid
AA00E9LX | MFCD00111707
63675-21-8
63675-21-8
1-(5-Chloro-methoxyphenyl)-5-oxo-3-pyrrolidinecarboxylic acid
AA00E9QE | MFCD04989732
650141-20-1
650141-20-1
2,6-Dimethyl-pyridine-3-carbaldehyde
AA00E9VY | MFCD03265780
627-86-1
627-86-1
DIOCTANOYLGLYCOL
AA00EA0V | MFCD00058489
6006-82-2
6006-82-2
3,4-(METHYLENEDIOXY)PHENETHYL ALCOHOL
AA00EA8C | MFCD00666033
6302-55-2
6302-55-2
1-(4-Chlorophenyl)butane-1,3-dione
AA00EADO | MFCD00463137
57520-17-9
57520-17-9
Guanidine, N,N'''-(iminodi-8,1-octanediyl)bis-, triacetate
AA00EAJB | MFCD01724078
59454-35-2
59454-35-2
4-Cyano-4'-decylbiphenyl
AA00EAOL | MFCD01218035
Submit
© 2017 AA BLOCKS, INC. All rights reserved.